Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Bavarian Nordic

Biotech & Life Sciences · Gentofte Municipality, Denmark · Founded 1994 · IPO 1998 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.61B
Market cap · Apr/2026
Revenue
$916M
Latest reported FY

Global footprint

Where Bavarian Nordic has talent and traffic

AI talent share
0.1% of workforce is AI talent
(2 of 1,730 staff)
Core AI00%
Other AI20.12%
Non-AI workforce1,72899.88%

Patent intelligence

$111M patent portfolio · 70 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$111M
6.9% of market cap · 4.8× the top peer SpringWorks Therapeutics ($23M)
70 active patent families
Where Bavarian Nordic innovates CarcinosisBiomedical engineeringTGE VACCINEDouble strandCancer research
Above peer median on Market

Quality vs same-sector peers

Bavarian Nordic on the five Patsnap quality dimensions

Bavarian Nordic in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Bavarian Nordic concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Bavarian Nordic and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Bavarian Nordic on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.